These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10663338)

  • 1. Recall phenomenon following epirubicin.
    Wilson J; Carder P; Gooi J; Nishikawa H
    Clin Oncol (R Coll Radiol); 1999; 11(6):424-5. PubMed ID: 10663338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
    Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
    Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
    Del Mastro L; Venturini M; Costantini M; Garrone O; Sertoli MR; Bertelli G; Machì AM; Rosso R
    J Natl Cancer Inst; 1997 Mar; 89(6):455-6. PubMed ID: 9091649
    [No Abstract]   [Full Text] [Related]  

  • 6. Epirubicin extravasation: consequences of delayed management.
    Hale O; Deutsch PG; Lahiri A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28062432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' concerns about clinical trials in Japan.
    Aoki E
    Lancet; 1999 Mar; 353(9157):1019-20. PubMed ID: 10459946
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.
    Meinardi MT; Van Der Graaf WT; Gietema JA; Van Den Berg MP; Sleijfer DT; De Vries EG; Haaksma J; Boomsma F; Van Veldhuisen DJ
    Heart; 2002 Jul; 88(1):81-2. PubMed ID: 12067953
    [No Abstract]   [Full Text] [Related]  

  • 9. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
    Joaquim AI; Sagarra AJ; Ramos CD; Coudry R; Sagarra RA; Camargo EE
    Clin Nucl Med; 1997 Sep; 22(9):638-40. PubMed ID: 9298303
    [No Abstract]   [Full Text] [Related]  

  • 10. Massive breast necrosis after extravasation of a full anthracycline cycle.
    Vasconcelos I; Schoenegg W
    BMJ Case Rep; 2013 Oct; 2013():. PubMed ID: 24142568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
    Denis F; Desbiez-Bourcier AV; Chapiron C; Arbion F; Body G; Brunereau L
    Eur J Surg Oncol; 2004 Dec; 30(10):1069-76. PubMed ID: 15522553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane.
    Uges JW; Vollaard AM; Wilms EB; Brouwer RE
    Int J Clin Oncol; 2006 Dec; 11(6):467-70. PubMed ID: 17180516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients.
    Chow LW; Loo WT; Wai CC; Lui EL; Zhu L; Toi M
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S298-301. PubMed ID: 16507397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
    Aigner B; Bauernhofer T; Petru E; Niederkorn A; Arzberger EJ; Richtig E
    Dermatology; 2014; 229(4):288-92. PubMed ID: 25472626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
    Nolan L; Darby A; Boleti K; Simmonds P
    Breast; 2011 Apr; 20(2):151-4. PubMed ID: 20970333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
    Ardavanis A; Orphanos G; Skafida S; Basioukas S; Rigatos G
    Ann Oncol; 2008 Jul; 19(7):1360-1361. PubMed ID: 18534961
    [No Abstract]   [Full Text] [Related]  

  • 18. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma.
    Beresford M; Lyburn I; Sanghera B; Makris A; Wong WL
    Breast J; 2007; 13(4):424-5. PubMed ID: 17593051
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative-pressure wound therapy and early pedicle flap reconstruction of the chest wall after epirubicin extravasation.
    Papadakis M; Rahmanian-Schwarz A; Bednarek M; Arafkas M; Holschneider P; Hübner G
    J Vasc Access; 2017 May; 18(3):e27-e29. PubMed ID: 28165571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.